Total Alkaline Phosphatase Research Articles

The Use of Ethanolic Extract of Sonchus Oleraceus in the Treatment of Hepatotoxicity Induced by Carbon Tetrachloride Injection in Rats

Purpose: To study the hepatoprotective activity of the ethanolic extract of Sonchus Oleraceus. The plant is of the family Asteraceas and was used in the traditional medicine for the treatment of gastrointestinal tract disorders, tumors and inflammatory diseases.
 Methodology: Sixty rats of both sexes were used, divided into 5 groups. The hepatotoxicity was induced by administration of carbon tetrachloride (CCL4) at dose rate of 0.2 mg /kg BW. The plant extract was administered orally at dose rates of 200 and 400 mg /kg BW.
 Findings: were compared to the standard drug known Silymarin at a dose rate of 100 mg/kg BW. The protective effect of ethanolic extract of Sonchus. Oleraceus was found to be better with the high dose (400 mg), hence the level of serum alanine amino transferase (ALT), serum Aspartate amino transferase (AST), were significantly decreased. Total protein, Albumin, Bilirubin and Alkaline Phosphatase (ALP) were also decreased, The Histological appearance of the given Sonchus Oleraceus. ethanolic extract (400mg/kg BW) showed few hepatocytes necrosis that has amorphous eosinophilic cytoplasm and areas of necrosis characterized by disintegration and disappearance of cells in many areas.
 Unique Contribution to Theory, Practice and Policy: According to the obtained results, it would be important to isolate the active ingredient of the plant used that responsible for the treatment of hepatotoxicity.

Effect of chitosan on common carp (Cyprinus carpio) fry growth performance, feed utilization and nutriphysiological status

The aim of research was to analyse the impact of chitosan supplementation (1% and 2% doses) on the nutriphysiological status (selected blood biochemical indicators, the microstructure of the intestine and liver and the mineral profile in the meat of common carp (Cyprinus carpio) fry (average 63 ± 4.9 g). The experiment was carried out with four replications per treatment, with 48 fish per tank in an open flow system. The average water temperature during the experiment was 20.7 °C, with a range from 18.0° to 22.8°C. The average water dissolved oxygen level was 4.6 mg dm−3 with a range of 4.0–6.2 mg dm−3. Experimental diets contained crude protein (37.5%) and crude fat (8.9%). There were no statistically significant differences between groups within the analysed growth and feed utilization parameters. As the blood analysis showed, chitosan supplementation significantly influenced (P < 0.05) the levels of total cholesterol (TCH), low-density lipoprotein (LDL), alkaline phosphatase (ALP), iron (Fe) and phosphorus (P). The 2% chitosan led to a reduction in the Fe level in the meat, and dietary supplementation with chitosan at both doses caused a significant increase (P < 0.05) in the concentration of Cu in this tissue. This confirms the properties of chitosan as a dietary fibre that inhibits the absorption of Fe in the intestine by reducing its bioavailability for mucosal cells. A significant increase (P < 0.05) in crypt depth and muscular layer thickness was observed with the increase in dietary chitosan. Histopathological examination of the liver showed significant differences in hepatocyte vacuolization between groups supplemented with 2% chitosan and the control. Only mild to moderate pathological changes and no severe pathological changes were observed between the experimental groups. The obtained results indicate that the chitosan used in the experiment showed both prebiotic and dietary fibre properties.

Overview of renal osteodystrophy in Brazil: a cross-sectional study.

The epidemiologic profile of renal osteodystrophy (ROD) is changing over time and cross-sectional studies provide essential information to improve care and health policies. The Brazilian Registry of Bone Biopsy (REBRABO) is a prospective, nationalmulticenter cohort that includes patients with chronic kidney disease (CKD) undergoing bone biopsy. REBRABO aims to provide clinical information on ROD. The main objective of this subanalysis was to describe the profile of ROD, including clinically relevant associations. From Aug/2015 to Dec/2021, 511 patients with CKD who performed bone biopsy were included in the REBRABO platform. Patients with no bone biopsy report (N = 40), GFR > 90 mL/min (N = 28), without asigned consent (N = 24), bone fragments inadequate for diagnosis (N = 23), bone biopsy indicated by a specialty other than nephrology (N = 6), and < 18 years old (N = 4) were excluded. Clinical-demographic data (e.g., age, sex, ethnicity, CKD etiology, dialysis vintage, comorbidities, symptoms, and complications related to ROD), laboratory (e.g., serum levels of total calcium, phosphate, parathormone, alkaline phosphatase, 25-hydroxyvitamin D, and hemoglobin), and ROD (e.g., histological diagnosis) were analyzed. Data from 386 individuals were considered in this subanalysis of REBRABO. Mean age was 52 (42-60) years; 198 (51%) were male; 315 (82%) were on hemodialysis. Osteitis fibrosa (OF) [163 (42%)], adynamic bone disease (ABD) [96 (25%)] and mixed uremic osteodystrophy (MUO) [83 (21%)] were the most frequent diagnosis of ROD in our sample; 203 (54%) had the diagnosis of osteoporosis, 82 (56%) vascular calcification; 138 (36%) bone aluminum accumulation, and 137 (36%) iron intoxication; patients with high turnover were prone to present a higher frequency of symptoms. A high proportion of patients were diagnosed with OF and ABD, as well as osteoporosis, vascular calcification and clinical symptoms.

Synthesis and In vivo Evaluation of Hepatoprotective Effects of Novel Sulfur-Containing 1,4-Dihydropyridines and 1,2,3,4-Tetrahydropyridines

Background: Hepatoprotectors, currently used in clinical practice, often show low efficacy. One of the promising goals in the therapy of liver diseases is the targeted synthesis of smallmolecule drugs with hepatoprotective activity. Some heterocycles, such as 1,4-dihydropyridines, are proven to be good hepatoprotectors. Objective: This study aimed to prepare and investigate the hepatoprotective effects of some dihydro- and tetrahydro pyridines using the experimental rat model of tetrachloromethane (CCl4)- induced acute liver damage. Methods: Several 1,4-dihydropyridines and 1,2,3,4-tetrahydropyridines were synthesized by the reaction of cyanothioacetamide with carbonyl compounds and active methylene compounds, such as Meldrum’s acid, ethyl cyanoacetate or β-keto esters, followed by S-alkylation of intermediate pyridine-2-thiolates. In silico prediction studies were performed to explore the possible protein targets. Using virtual bioscreening tools, we selected the six most promising compounds from the library of new partially saturated pyridines. Six novel compounds were characterized by IR, 1H, 13C DEPTQ NMR spectroscopy, 2D NMR experiments (1H–13C HSQC, 1H–13C HMBC), HRMS (ESI), and elemental analysis. The hepatoprotective effects were studied in vivo on eighty white rats with CCl4-induced liver damage. Biochemical studies, including thymol turbidity test and measurements of levels of bilirubin, alanine aminotransferase, aspartate aminotransferase and alkaline phosphatase in the blood of rats, were performed. Results: Five of six studied compounds showed a good hepatoprotective effect on a rat model of tetrachloromethane (CCl4)-induced acute hepatitis. The blood of rats in the experimental groups revealed significantly lower levels of total bilirubin, alanine aminotransferases, aspartate aminotransferases, thymol turbidity and alkaline phosphatase compared to the control group of rats with acute toxic tetrachloromethane hepatitis. Conclusion: Our results suggests that compound, (benzyl 4-(4-chlorophenyl)-5-cyano-6-({2-[(3,4- dimethylphenyl)amino]-2-oxoethyl}thio)-2-methyl-1,4-dihydropyridine-3-carboxylate), can be considered as candidate for further preclinical studies. Moreover, as per our knowledge, this is the first report on the hepatoprotective effects of the 1,2,3,4-tetrahydropyridine series.

Behavior of total alkaline phosphatase after radium-233 therapy in metastatic castration-resistant prostate cancer: a single-center, real-world retrospective study.

To describe the behavior of total alkaline phosphatase (tALP) in patients with metastatic castration-resistant prostate cancer receiving radium-223 therapy, in a real-world scenario, and to describe overall survival (OS) among such patients. This was a retrospective study involving 97 patients treated between February 2017 and September 2020. Patients were stratified by the baseline tALP (normal/elevated). A tALP response was defined as a ≥ 30% reduction from baseline at week 12. For patients with elevated baseline tALP, we also evaluated treatment response as a ≥ 10% reduction in tALP after the first cycle of treatment. We defined OS as the time from the first treatment cycle to the date of death. There was a significant reduction in the median tALP after each cycle of treatment (p < 0.05 for all). Data for tALP at week 12 were available for 71 of the 97 patients. Of those 71 patients, 26 (36.6%) responded. Elevated baseline tALP was observed in 47 patients, of whom 19 (40.4%) showed a response. Longer OS was observed in the patients with normal baseline tALP, in those with elevated baseline tALP that showed a response to treatment (≥ 10% reduction), and in those who received 5-6 cycles of therapy. The tALP may be used to predict which patients will benefit from treatment with a greater number of cycles of radium-223 therapy and will have longer OS.

Clinical-radiological, hematological and biochemical assessment of bone replacement with germanium-doped calcium-phosphate ceramics for fragment fractures of tubular bones in dogs

Abstract. Among surgical pathology in animals, asignificant share is occupied by various traumatic injuries of the skeleton, the consequence of which are bonefractures. The results of X-ray and biochemical indicators of blood for bone fragment fractures in dogs arepresented.The purpose of the work is to clinically, radiologically, and pathochemically justify bone replacementwith germanium-doped calcium-phosphate ceramicsfor bone fragment fractures in dogs.In the injured animals of the experimental group(n=10), bone defects were replaced with germanium-doped calcium-phosphate ceramics (ГТлГег-700),in the control group (n=10) with unalloyed ceramics(ГТг-700). The activity of total alkaline phosphatase (ALP)and its bone isoenzyme (KiLP), tartrate-resistant acidphosphatase (TrKF) was determined in blood serum.Measurements were made with a Stat Fax 4500 spectrophotometer.On the 60th day, in the animals of the experimentalgroup, the filling of the bone defect with regeneratedmaterial of high X-ray density was noted, with the absence of periosteal reaction, which indicated the complete consolidation of the fracture and was the reasonfor the removal of the means of fixation. In the control,the area of the bone tissue defect that was not filledwith regenerate was visualized.The activity of tartrate-resistant acid phosphatase(TRP) in both groups tended to increase. On the 14th day,the animals of the experimental group had a peak activity of TrKf (33.8±0.31), which was 1.3 times (p&lt;0.001)higher than the level in the control group and 1.5 times(p&lt;0.001) of clinically healthy animals, respectively. Onthe 30th day of research, a 1.2-fold (p&lt;0.001) decreasein the level of TrCF was noted in the experimental groupcompared to the control group, in which the indicatorreached peak values at 34.9±0.25 units/l.The maximum activity of the bone isoenzyme alkaline phosphatase (KiLF) in the experimental groupwas observed on the 14th day of reparative osteogenesis and was 41.7±0.43 units/l, which is 1.2 times(p&lt;0.001) higher than the indicator of the controlgroup. On the other hand, in the last group, the peakactivity of the bone isozyme was noted only on the30th day (40.9±0.48 units/l), while the indicator of theexperimental animals decreased dynamically duringthis period.The use of calcium-phosphate ceramics for fragment fractures of the bones of the tibia in dogs helpsto reduce the intensity of the inflammatory-resorptivestage of reparative osteogenesis and accelerates consolidation by 1.4 times. The dynamics of biochemicalmarkers of bone metabolism testifies to the optimizedcourse of reparative osteogenesis during osteoreplacement of bone defects with germanium-doped calcium-phosphate ceramics. Key words: bioceramics, germanium, total alkaline phosphatase, bone isoenzyme of alkaline phosphatase, tartrate-resistant acid phosphatase, bonetissue.

Synthesis, molecular docking, and protective effect of novel thiohydantoin derivative: (Z)-5-(pyridin-2-ylmethylene)-2-thioxothiazolidin-4-one in a diethynitrosamine model of hepatotoxicity

BackgroundDiethyl nitrosamine (DEN) consumption was well documented to cause liver cell damage, compensatory proliferation, and inflammation, so this study aimed to examine the hepatoprotective effects of (Z)-5-(pyridin-2-ylmethylene)-2-thioxothiazolidin-4-one (Z5–2T) on diethyl nitrosamine (DEN) induced liver damage in a rat model. MethodsThirty male wistar rats were divided into three groups, each with ten rats, as the following, Group 1: Vehicle (normal saline), group 2: DEN control, 200 mg/kg single dose injection intraperitonially, group 3: were given 50 mg/kg by oral feeding of (Z5–2T). Five rats from each group were sacrificed in the second week of the experiment, and the other half were sacrificed in the sixth week. Resultsinjection of 200 mg/kg of DEN to rats resulted in elevation of liver function enzymes Total Bilirubin (8.02 ± 0.1 mg/dL), direct Bilirubin (8.22 ± 0.2 mg/dL), indirect Bilirubin (0.03 ± 0.03 mg/dL), aspartate Aminotransferase (303 ± 1.2 U/L), alanine Aminotransferase (287 ± 0.9 U/L) and alkaline Phosphatase (390 ± 0.6 U/L) indicating liver damage, along with elevation in the TNF-α and IL-6. The results of both LFTs and ELISA in the treatment group showed improvements and exhibited decline in the levels of the markers. Histopathological examination showed fibrosis, necrosis, and infiltration of inflammatory cells in DEN group, with less intensity in the treatment group. Immunohistochemistry staining reveled strong positive staining of both HSA and ki-67 antibodies in the DEN group, with much less intensity in the treatment group. The correct absorption and binding between the drug and the receptor were evaluated through computerized molecular docking by using AutoDock program. (Z5–2T) had remarkable interaction with TNF-α (PDB ID:1TNF) and IL-6 (PDB ID: 1IL6), binding site energy -6.5 and -6.0 (kcal/mol), respectively. Conclusionhepatoprotective effect of the (Z5–2T) against DEN-induced hepatocellular damage and cancer in experimental rats was accomplished.

Decline in clinical severity of Paget's disease of bone: Comparison between a contemporary cohort and a historical cohort.

European and Australian studies have reported a decrease in the prevalence, incidence and clinical severity of Paget's disease of bone (PDB). There are no studies on the current clinical characteristics of PDB in Quebec, Canada. The purpose of this study was to describe the characteristics of unrelated patients with PDB diagnosed after the year 2000 in our region and to compare them to a historical cohort diagnosed before 2000. In this retrospective descriptive cohort study, socio-demographic data and clinical characteristics for the contemporary cohort were collected from electronic medical records of patients with PDB followed at our university hospital. For the historical cohort, the same data were collected from the research files of PDB participants in our research program. Inclusion criteria were: age>18years, having PDB diagnosed by a rheumatologist, and being followed in our hospital. Exclusion criteria were: having a relative with PDB participating in this study. Variables were reported as mean, standard deviation, frequency and percentage. Chi-square tests were used to compare categorical variables. Continuous values were compared with Wilcoxon-Mann-Whitney tests. Unadjusted p-values and adjusted p-values with the Bonferroni correction method were calculated. A p-value <0.05 was considered statistically significant. Among the 195 patients with PDB in the contemporary cohort, 53.3% were men, 60.5% had monostotic involvement, 14.2% were symptomatic at diagnosis. In comparison to the historical cohort of 173 patients, patients in the contemporary cohort were older at diagnosis (68.710.7 vs. 58.510.1; p<0.0001) and had less family history of PDB (13.8% vs. 33.6%; p=0.0024). They also had lower total alkaline phosphatase levels at diagnosis (118.0 (85.0-184.0)) vs. 184.0 (115.0-312.0)); p=0.0006), a lower pagetic bone number (1.0 (1.0-3.0) vs. 2.0 (1.0-5.0); p<0.0001), lower pagetic bone fractures (6.7% vs. 36.7%; p=0.0078) and lower bone deformities (13.0% vs. 54.0%; p<0.0001). There was no significant difference for pagetic bone pain (52.0% vs. 52.6%; p=1.0000), percentage of patients who had orthopedic surgery related to PDB complications (8.8% vs. 28.6%; p=1.0000), secondary osteoarthritis (43.0% vs. 51.6%; p=1.0000), and hearing impairment (51.9% vs. 61.1%; p=0.1000). The contemporary cohort is characterized by an older age at diagnosis, a majority of monostotic disease and fewer complications of PDB. This decline in clinical severity of PDB in Quebec is consistent with studies reported in other countries.

Vitamin C as a potential ameliorating agent against hepatotoxicity among alcoholic abusers.

Drug and substance abuse remains a major medical problem globally. Alcohol consumption, particularly heavy drinking, is an important risk factor for many health problems and is a major contributor to the global burden of disease. Vitamin C has proven to be defensive against toxic substances and provides antioxidant and cytoprotective activity to hepatocytes. The aim of this study was to investigate vitamin C as a potential ameliorating agent against hepatotoxicity among alcohol abusers. This study was a cross-sectional study that included eighty male hospitalized alcohol abusers and twenty healthy people as a control group. Alcohol abusers received standard treatment plus vitamin C. Total protein, albumin, total Bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), thiobarbituric acid reactive substances (TBARS), reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT) and 8-hydroxhguanosine (8-OHdG) were investigated. This study reported that, in the alcohol abuser group, there was a significant increase in the total protein, bilirubin, AST, ALT, ALP, TBARS, SOD and 8-OHdG; on the other hand, there was a significant decrease in albumin, GSH and CAT compared with the control group. The alcohol abuser group treated with vitamin C showed a significant decrease in total protein, bilirubin, AST, ALT, ALP, TBARS, SOD and 8-OHdG; on the other hand, there was a significant increase in albumin, GSH and CAT compared with the control group. This study's findings suggest that alcohol abuse induces significant alterations in various hepatic biochemical parameters and oxidative stress and that vitamin C has a partial protective role in countering alcohol abuse-induced hepatotoxicity. Using vitamin C as an adjunctive supplement to standard treatment may be helpful in minimizing the toxic side effects of alcohol abuse.

Percutaneous transhepatic intraluminal forceps biopsy for patients with biliary stricture after endoscopic retrograde approach failure: a retrospective study.

The etiological diagnosis of biliary stricture remains a clinical challenge. Currently, endoscopic retrograde cholangiopancreatography (ERCP)-guided biliary biopsy is the most commonly used technique. This retrospective study aimed to evaluate the clinical value of percutaneous transhepatic intraluminal forceps biopsy (TIFB) in patients with biliary stricture after ERCP failure. The clinical data of 240 consecutive patients with biliary strictures who sought further etiologic diagnosis at our center between April 2014 and January 2020 were collected. After the exclusion of 197 patients who underwent ERCP-guided biopsy, 43 patients who received TIFB after ERCP failure were included in the study. The primary outcomes were technical success, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy. Secondary outcomes included procedure duration, radiation exposure, liver function [total bilirubin (TB), direct bilirubin (DB), γ-glutamyl transferase (GGT), alkaline phosphatase (ALP), alanine aminotransferase (ALT), and aspartate aminotransferase (AST)] preoperatively and at 2 weeks postoperatively, and complications. The technical success rate of TIFB was 100%. The diagnostic sensitivity, specificity, accuracy, PPV, and NPV of TIFB were 82.35%, 100%, 86.05%, 100%, and 60%, respectively. The accuracy of TIFB was significantly higher for cases with suspicious biliary tract invasion on imaging and intrabiliary malignant origin than it did for cases with no suspicious biliary tract invasion on imaging or extrabiliary malignant origin (P=0.007 and P=0.003, respectively). Only intrabiliary malignant origin (P=0.02) was an independent contributing factor for a true positive result in TIFB diagnosis. The mean procedure duration was 19.3 minutes and the mean radiation exposure was 315.6 mGy. All liver function markers were significantly reduced after 2 weeks (all P<0.001). Three (6.97%) complications occurred, including 1 (2.33%) case of cholangitis and 2 (4.65%) cases of hemobilia. Percutaneous TIFB is an effective method with high sensitivity and accuracy for the etiological diagnosis of biliary stricture after ERCP failure.

Effect of Acute Toxicity of Lead Nitrate on Serum Biochemical and Enzymological Parameters of Indian Major Carp, Labeo rohita

To determine the LC 50 value of lead nitrate, Labeo rohita were exposed to different concentrations of the heavy metal through static assay method. LC50 value was calculated by employing Probit analysis and its acute toxicity was found to be 851mg/L. The acute toxic effect of lead nitrate on serum biochemical parameters of Labeo rohita were studied through 96-hour acute toxicity assay. Significant alterations were noticed in serum biochemical parameters viz. Total protein, Albumin, Globulin, and enzymes like Serum glutamate oxalate transaminase (SGOT), Serum glutamate pyruvate transaminase (SGPT) and Alkaline phosphatase (ALP). There was an increase in the mean values of total protein, albumin, globulin, SGOT, SGPT and ALP in lead nitrate exposed fishes when compared to the control fishes, but fluctuations were noticed in the ALP mean values.

A Mouse Model with a Frameshift Mutation in the Nuclear Factor I/X (NFIX) Gene Has Phenotypic Features of Marshall-Smith Syndrome.

The nuclear factor I/X (NFIX) gene encodes a ubiquitously expressed transcription factor whose mutations lead to two allelic disorders characterized by developmental, skeletal, and neural abnormalities, namely, Malan syndrome (MAL) and Marshall-Smith syndrome (MSS). NFIX mutations associated with MAL mainly cluster in exon 2 and are cleared by nonsense-mediated decay (NMD) leading to NFIX haploinsufficiency, whereas NFIX mutations associated with MSS are clustered in exons 6-10 and escape NMD and result in the production of dominant-negative mutant NFIX proteins. Thus, different NFIX mutations have distinct consequences on NFIX expression. To elucidate the in vivo effects of MSS-associated NFIX exon 7 mutations, we used CRISPR-Cas9 to generate mouse models with exon 7 deletions that comprised: a frameshift deletion of two nucleotides (Nfix Del2); in-frame deletion of 24 nucleotides (Nfix Del24); and deletion of 140 nucleotides (Nfix Del140). Nfix +/Del2, Nfix +/Del24, Nfix +/Del140, Nfix Del24/Del24, and Nfix Del140/Del140 mice were viable, normal, and fertile, with no skeletal abnormalities, but Nfix Del2/Del2 mice had significantly reduced viability (p < 0.002) and died at 2-3 weeks of age. Nfix Del2 was not cleared by NMD, and NfixDel2/Del2 mice, when compared to Nfix +/+ and Nfix +/Del2 mice, had: growth retardation; short stature with kyphosis; reduced skull length; marked porosity of the vertebrae with decreased vertebral and femoral bone mineral content; and reduced caudal vertebrae height and femur length. Plasma biochemistry analysis revealed Nfix Del2/Del2 mice to have increased total alkaline phosphatase activity but decreased C-terminal telopeptide and procollagen-type-1-N-terminal propeptide concentrations compared to Nfix +/+ and Nfix +/Del2 mice. Nfix Del2/Del2 mice were also found to have enlarged cerebral cortices and ventricular areas but smaller dentate gyrus compared to Nfix +/+ mice. Thus, Nfix Del2/Del2 mice provide a model for studying the in vivo effects of NFIX mutants that escape NMD and result in developmental abnormalities of the skeletal and neural tissues that are associated with MSS. © 2023 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.

Biochemical blood profile in water buffalo: alterations related to natural infection by Trypanosoma spp.

Blood and biochemical profiles of animals can be used to evaluate the physiological state of an individual and relate it to that individual’s health. In many countries, water buffaloes are currently evaluated using blood parameters from other bovine species. To accurately interpret the biochemical results from individual animals, species-specific reference ranges should be established. One hundred and twenty-eight water buffaloes, without clinical signs of disease and of different ages, were analyzed, and reference intervals were calculated (95% CI; p &lt; 0.05). The data were analyzed according to three age groups (calves, young animals, and adults) and the infection status (infected or uninfected with Trypanosoma spp.). All the biochemical values of total serum proteins, aspartate aminotransferase, gamma globulin, urea nitrogen, calcium, and phosphorus were included; these are parameters that are generally affected by parasites or by infection with hemotropic agents. Natural infection with Trypanosoma spp. gave rise to differences (p &lt; 0.05) in terms of increased calcium and decreased total protein, alkaline phosphatase, and aspartate aminotransferase. Thus, it can be inferred that the infection follows a chronic course in the affected animals, in this case, young animals or young animals.

Factors and cytokine signatures associated with the response to therapy in patients with primary biliary cholangitis-autoimmune hepatitis overlap syndrome: a real-world study.

Factors and cytokine signatures associated with the response to therapy in patients with primary biliary cholangitis-autoimmune hepatitis overlap syndrome: a real-world study.

The Preclinical Benefit of Glutamine in bisphenol A-induced Hepatotoxicity in Wistar Rats

Background: Oxidative stress may be a causative factor for bisphenol A (BPA) -induced hepatotoxicity. Glutamine (GM) is an amino acid with the ability to inhibit oxidative stress. Objective: This study evaluated the ability of GM to prevent BPA-induced hepatotoxicity in rats. Methods: Adult Wistar rats of both sexes (n=30) were used. The rats were randomly grouped into six of five rats each. Groups A (Control), B, and C were treated with normal saline (0.2 mL), GM (80 mg/kg), and BPA (50 mg/kg), respectively for 60 days. Groups D-F were treated with GM (20 mg/kg)+BPA (50 mg/kg), GM (40 mg/kg)+BPA (50 mg/kg), and GM (80 mg/kg)+BPA (50 mg/kg), respectively for 60 days. After treatment, blood and liver samples were obtained for biochemical and histological assessments, respectively. Results: Significantly (P&lt;0.01) decreased body weight and significantly (P&lt;0.01) increased liver weight occurred in the BPA-administered group when compared to the control group. The BPA-administered group showed significantly (P&lt;0.001) elevated serum total bilirubin, lactate dehydrogenase, aminotransferases, conjugated bilirubin, gamma-glutamyl transferase, alkaline phosphatase, and liver malondialdehyde concentrations when compared to the control group. Significantly (P&lt;0.001) decreased liver superoxide dismutase, glutathione peroxidase, catalase, and glutathione levels occurred in the PBA-administered group when compared to the control group. BPA caused hepatocyte necrosis, sinusoids, and central vein congestion. BPA-induced hepatotoxicity was reversed by GM; 20 mg/kg (P&lt;0.05), 40 mg/kg (P&lt;0.01), and 80 mg/kg (P&lt;0.001) in a dose-related fashion when compared to BPA. Conclusion: GM may be effective against BPA-associated hepatotoxicity.

Bone turnover markers and bone mineral density in patients with type 2 diabetes

Background: This study was designed in order to evaluate bone and mineral metabolism in type 2 diabetic patients and its relationship with bone mineral density and diabetic microvascular complications. Methods: Forty two type 2 diabetic patients and 23 healthy cases were included in the study. Serum osteocalcin, procollagen type 1 – C peptide (PICP), total and bone specific alkaline phosphatase (bone ALP), urinary deoxypyridinoline (free DPD), parathormone (PTH), serum and urinary calcium and phosphorus levels were measured. Bone mineral densities of all subjects were studied in lumbar vertebra and femur region using dual X-ray absorptiometry (DXA). Results: Serum osteocalcin and bone ALP levels of the diabetics were found to be significantly lower and total alkaline phosphatase and calcium levels were higher in diabetic patients compared to healthy controls, but PICP and free DPD levels were not different between these two groups. There was a positive correlation between PTH levels and urinary DPD excretion. Among diabetics, serum osteocalcin levels increased with the impairment of renal functions. Bone mineral densities were lower in diabetics with worse renal functions. Conclusion: Bone turnover is slow in type 2 diabetes and there is no prominent bone loss related to this condition. PTH is an important factor determining the rate of bone resorption in diabetics. Renal functional impairment is the most important factor affecting the bone mass in type 2 diabetic patients.

Resolution of Liver Function Tests After Laparoscopic Common Bile Duct Exploration Versus Endoscopic Retrograde Cholangiopancreatography.

Laparoscopic cholecystectomy (LC) with laparoscopic common bile duct exploration (LCBDE) is gaining traction for the management of choledocholithiasis. Liver function tests (LFTs) are often used to determine the success of ductal clearance, yet the impact of differing therapeutic interventions, endoscopic retrograde cholangiopancreatography (ERCP) or LCBDE, have on postprocedure LFT is insufficiently described. We hypothesize that these interventions have different postoperative LFT profiles. The preprocedural and postprocedural total bilirubin (Tbili), aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP) were analyzed of 167 patients who had successful ERCPs (117) or LCBDEs (50). Endoscopic retrograde cholangiopancreatography patients demonstrated a significant decrease in all LFTs postprocedure (n = 117; P = <0.001 for all) with a continued downtrend when a second set of LFTs was obtained (n = 102; P = <0.001 for all). For successful LC+LCBDEs, there was no significant change between preoperative and 1st postoperative Tbili, AST, ALT, and ALP and the 2nd postoperative labs.

Pemanfaatan Alkaline Phosphatase sebagai Novel Biomarker Deteksi dalam Diagnosis Osteoporosis selama Pandemi COVID-19

Osteoporosis is a bone disorder characterized by reduced bone mass density so that bones become brittle and increase the risk of fractures. It develops slowly over several years and is often only diagnosed when a fall or sudden impact causes a bone to break (fracture). The incidence of osteoporosis always increase every year and it is estimated that patient with osteoporosis in Indonesia will increase to be 300 millions people in 2050. One of several ways to diagnose osteoporosis is through specific biomarkers that marked formation, resorption and reulation during bone remodeling processes. Various biomarkers are now available for specific and sensitive assessment of the rate for bone formation and bone resorption. For example, the bone formation biomarkers are total alkaline phosphatase (ALP), bone-specific alkaline phosphatase (BALP), osteocalcin (OC), procollagen type 1 N-terminal propeptide (P1NP) and procollagen type 1 C-terminal propeptide (P1CP). Moreover, the decrease of total ALP has been demonstrated with the treatment with alendronate from 79.7 U/L to 64.8 U/L. This literature review is aimed to discuss the utilization of alkaline phosphatase as a novel detection biomarker in the diagnosis of osteoporosis during the COVID-19 pandemic. The literature based on journal searching related to the topic such as, PubMed, Science Direct, and Google Scholar. Researcher have obtained the basis of the disease, the underlying mechanism explains and the detection, through the specificity researcher can see how it may be effective as a biomarker, and the comparison may reveal it’s potential and how it compares to other biomarkers.

Investigation of Vitamin a and 25(OH)D3 Levels in Cattle with Pneumonia Detected Mycoplasma bovis

Abstract This study investigated the presence of Mycoplasma bovis in nasal swabs taken from cattle with pneumonia, to reveal the clinical and biochemical findings of positive animals, and determine the levels of vitamin A and 25(OH)D3. In the study were included 103 infected cattle and 10 healthy cattle, all aged 1-4 years, as the control group. Quantitative clinical evaluations and clinical examinations were performed on each animal, and 5 ml blood samples and nasal swabs were taken. Serum biochemistry, vitamin A and 25(OH)D3 levels were determined in both positive and control samples. The clinical signs were identified by qualitative scoring in M. bovis positive animals. Regarding the clinical findings, respiratory frequency, heart rate, and rectal temperature were significantly higher in positive than control group animals (p&lt;0.001). Regarding the biochemistry findings, albumin (ALB) and glucose (GLU) levels were lower in cattle infected with M. bovis (p&lt;0.001) whereas total protein (TP) and alkaline phosphatase (ALP) levels were higher (p&lt;0.001). While serum 25(OH)D3 levels were lower in infected animals (p&lt;0.001), there was no significant difference (p&gt;0.05) in serum vitamin A levels. In this study, clinical findings in cattle naturally infected with M. bovis were expressed qualitatively and quantitatively. In addition, it has been revealed that the disease does not only cause lung involvement, but also causes changes in biochemical and vitamin levels. Although these parameters cannot be used as a biomarker in the diagnosis of pneumonia, they are thought to provide benefits in terms of diagnosis, treatment and prophylaxis in practice.

Noncirrhotic portal hypertension misdiagnosed as liver cirrhosis: A rare case

Noncirrhotic portal hypertension misdiagnosed as liver cirrhosis: A rare case